960 related articles for article (PubMed ID: 17966885)
61. Diagnosis of patients with raised serum calcium level in primary care, Sweden.
Dalemo S; Hjerpe P; Boström Bengtsson K
Scand J Prim Health Care; 2006 Sep; 24(3):160-5. PubMed ID: 16923625
[TBL] [Abstract][Full Text] [Related]
62. [Surgical treatment of asymptomatic primary hyperparathyroidism].
Zhou JP; Zhang H; Dong M; Kong FM; Tian YL; Liu YF
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1483-5. PubMed ID: 19094627
[TBL] [Abstract][Full Text] [Related]
63. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
Caron P; Maiza JC; Renaud C; Cormier C; Barres BH; Souberbielle JC
Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355
[TBL] [Abstract][Full Text] [Related]
64. Sclerostin and DKK1 in primary hyperparathyroidism.
Viapiana O; Fracassi E; Troplini S; Idolazzi L; Rossini M; Adami S; Gatti D
Calcif Tissue Int; 2013 Apr; 92(4):324-9. PubMed ID: 23430197
[TBL] [Abstract][Full Text] [Related]
65. Surgical pathology of the thyroid gland in Iraq. A study of 200 cases.
Al-Saleem T; Al-Ashbal A
Int Surg; 1973 Sep; 58(9):623-7. PubMed ID: 4800296
[No Abstract] [Full Text] [Related]
66. Are biochemical values predictive of adenoma's weight in primary hyperparathyroidism?
Hamidi S; Aslani A; Nakhjavani M; Pajouhi M; Hedayat A; Kamalian N
ANZ J Surg; 2006 Oct; 76(10):882-5. PubMed ID: 17007616
[TBL] [Abstract][Full Text] [Related]
67. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
68. Coincidence of primary hyperparathyroidism and nonmedullary thyroid carcinoma.
Lehwald N; Cupisti K; Krausch M; Ahrazoglu M; Raffel A; Knoefel WT
Horm Metab Res; 2013 Sep; 45(9):660-3. PubMed ID: 23757116
[TBL] [Abstract][Full Text] [Related]
69. Observations on the course of untreated primary hyperparathyroidism.
Corlew DS; Bryda SL; Bradley EL; DiGirolamo M
Surgery; 1985 Dec; 98(6):1064-71. PubMed ID: 3878002
[TBL] [Abstract][Full Text] [Related]
70. Normocalcemic hyperparathyroidism in patients with osteoporosis.
Monchik JM; Gorgun E
Surgery; 2004 Dec; 136(6):1242-6. PubMed ID: 15657582
[TBL] [Abstract][Full Text] [Related]
71. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.
Shah VN; Bhadada SK; Bhansali A; Behera A; Mittal BR; Bhavin V
J Postgrad Med; 2012; 58(2):107-11. PubMed ID: 22718053
[TBL] [Abstract][Full Text] [Related]
72. Incidence and clinical behavior of papillary thyroid carcinoma in renal allograft recipients: a single center experience.
Lee J; Jeong JJ; Lee YS; Nam KH; Chang HS; Chung WY; Soh EY; Kim YS; Park CS
Transplant Proc; 2008 Dec; 40(10):3751-4. PubMed ID: 19100481
[TBL] [Abstract][Full Text] [Related]
73. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
[TBL] [Abstract][Full Text] [Related]
74. Primary hyperparathyroidism in Northern Sweden.
Kristoffersson A; Dahlgren K; Granstrand B; Järhult J
Surg Gynecol Obstet; 1987 Feb; 164(2):119-23. PubMed ID: 3810425
[TBL] [Abstract][Full Text] [Related]
75. Prevalence of cortical osteoporosis in mild and severe primary hyperparathyroidism and its relationship with bone markers and vitamin D status.
Bandeira F; Griz LH; Bandeira C; Pinho J; Lucena CS; Alencar C; Thé AC; Diniz ET
J Clin Densitom; 2009; 12(2):195-9. PubMed ID: 19138544
[TBL] [Abstract][Full Text] [Related]
76. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
77. A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease.
Riss P; Kaczirek K; Heinz G; Bieglmayer C; Niederle B
Surgery; 2007 Sep; 142(3):398-404. PubMed ID: 17723893
[TBL] [Abstract][Full Text] [Related]
78. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
Lim V; Clarke BL
J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
[TBL] [Abstract][Full Text] [Related]
79. Does hyperparathyroidism cause pancreatitis? A South Indian experience and a review of published work.
Jacob JJ; John M; Thomas N; Chacko A; Cherian R; Selvan B; Nair A; Seshadri M
ANZ J Surg; 2006 Aug; 76(8):740-4. PubMed ID: 16916398
[TBL] [Abstract][Full Text] [Related]
80. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center.
Zhao L; Liu JM; He XY; Zhao HY; Sun LH; Tao B; Zhang MJ; Chen X; Wang WQ; Ning G
J Clin Endocrinol Metab; 2013 Feb; 98(2):721-8. PubMed ID: 23365127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
